The Riverview site provides comprehensive drug substance development and manufacturing services, including spec ...

U.S. warplanes struck Iran’s nuclear sites in a dramatic escalation—just the latest in a long, bloody pattern. From proxy ...

Zelos Group Inc, a Suzhou, Jiangsu province-based developer of Level 4 autonomous logistics vehicles, will ramp up efforts to ...

"Syensqo aims to double our performance in China to meet the high and increasingly sophisticated demand in the country, the ...

Mesoblast's RYONCIL ® (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA approved mesenchymal ...